Skip to content
10-Q

Quarterly Report

Rapport Therapeutics, Inc. RAPP

0001193125-25-268096

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 47.66M sh
Shares Diluted Q3 2025 · Sep 30, 2025 37.93M sh
Shares Diluted Q3 2025 · Sep 30, 2025 36.22M sh
Shares Diluted Q3 2025 · Sep 30, 2024 34.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 15.93M sh
Capex Q3 2025 · Sep 30, 2025 $447K
Capex Q3 2025 · Sep 30, 2024 $2.18M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$62.77M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$50.38M
Short Term Investments Q3 2025 · Sep 30, 2025 $261.67M
Short Term Investments Q3 2025 · Dec 31, 2024 $248.48M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $251.36M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $56.81M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $39.31M
Stockholders Equity Q3 2025 · Sep 30, 2025 $511.62M
Stockholders Equity Q3 2025 · Jun 30, 2025 $263.51M
Stockholders Equity Q3 2025 · Mar 31, 2025 $285.84M
Stockholders Equity Q3 2025 · Dec 31, 2024 $305.43M
Stockholders Equity Q3 2025 · Sep 30, 2024 $323.11M
Stockholders Equity Q3 2025 · Jun 30, 2024 $336.89M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$39.63M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$25.63M
Current Liabilities Q3 2025 · Sep 30, 2025 $14.32M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.77M
Total Liabilities Q3 2025 · Sep 30, 2025 $23.71M
Total Liabilities Q3 2025 · Dec 31, 2024 $9.51M
Current Assets Q3 2025 · Sep 30, 2025 $520.66M
Current Assets Q3 2025 · Dec 31, 2024 $309.8M
Total Assets Q3 2025 · Sep 30, 2025 $535.32M
Total Assets Q3 2025 · Dec 31, 2024 $314.93M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.71
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.15
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.50
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.66
Eps Basic Q3 2025 · Sep 30, 2025 −$0.71
Eps Basic Q3 2025 · Sep 30, 2025 −$2.15
Eps Basic Q3 2025 · Sep 30, 2024 −$0.50
Eps Basic Q3 2025 · Sep 30, 2024 −$3.66
Rd Expense Q3 2025 · Sep 30, 2025 $22.28M
Rd Expense Q3 2025 · Sep 30, 2025 $64.53M
Rd Expense Q3 2025 · Sep 30, 2024 $15.54M
Rd Expense Q3 2025 · Sep 30, 2024 $43.74M
Net Income Q3 2025 · Sep 30, 2025 −$26.93M
Net Income Q3 2025 · Sep 30, 2025 −$77.72M
Net Income Q3 2025 · Jun 30, 2025 −$26.73M
Net Income Q3 2025 · Mar 31, 2025 −$24.06M
Net Income Q3 2025 · Dec 31, 2024 −$78.3M
Net Income Q3 2025 · Sep 30, 2024 −$17.54M
Net Income Q3 2025 · Sep 30, 2024 −$58.33M
Net Income Q3 2025 · Jun 30, 2024 −$18.12M
Net Income Q3 2025 · Mar 31, 2024 −$22.67M
Operating Income Q3 2025 · Sep 30, 2025 −$29.99M
Operating Income Q3 2025 · Sep 30, 2025 −$86.59M
Operating Income Q3 2025 · Sep 30, 2024 −$21.64M
Operating Income Q3 2025 · Sep 30, 2024 −$59.53M